Skip to content

Ashraf Kamour

2 papers in the library · 23 citations · publishing 2014-2016

Papers

Sort Most recent Most cited

Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.

Clinical toxicology (Philadelphia, Pa.) September 1, 2016 Simon L Hill, Javad Najafi, Michael Dunn et al.

Recreational use of Synthetic Cannabinoid Receptors Agonists (SCRAs) has become increasingly common in many countries and may cause severe toxic effects. To describe the clinical features of toxicity in seven men after analytically confirmed exposure to MDMB-CHMICA, a recently described indole-based SCRA. Clinical information and biological samples (blood, urine) were collected from patients...

Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom. A report from the UK National Poisons Information Service

Clinical Toxicology February 28, 2014 Ashraf Kamour, David A. James, Robert Spears et al. 23 citations

OBJECTIVE: To characterise the patterns of presentation, clinical effects and possible harms of acute toxicity following recreational use of alpha methyltryptamine (AMT) in the United Kingdom, as reported by health professionals to the National Poisons Information Service (NPIS) and to compare clinical effects with those reported after mephedrone use. METHODS: NPIS telephone enquiries and...